Reverse Transcriptase Inhibitors (RTIs) are part of the cocktail of medicines used to treat HIV. So what do they have to do with AGS and why are we starting clinical trials? As of February 2023, there are 3 AGS clinical trials with reverse transcriptase inhibitors either active or about to begin in Europe and the United States. Learn about the theory and why they’re expected to be helpful.